Edition:
United Kingdom

TherapeuticsMD Inc (TXMD.OQ)

TXMD.OQ on NASDAQ Stock Exchange Global Select Market

5.11USD
18 Jan 2019
Change (% chg)

$-0.13 (-2.48%)
Prev Close
$5.24
Open
$5.24
Day's High
$5.34
Day's Low
$5.10
Volume
661,137
Avg. Vol
663,719
52-wk High
$7.66
52-wk Low
$3.51

Select another date:

Mon, Oct 29 2018

FDA approves TherapeuticsMD's menopause drug

The U.S. Food and Drug Administration (FDA) approved TherapeuticsMD's oral hormone therapy for menopause symptoms such as hot flashes, sleep disturbances and night sweats, the company said on Monday.

UPDATE 1-U.S. FDA approves TherapeuticsMD's menopause drug

Oct 29 The U.S. Food and Drug Administration (FDA) approved TherapeuticsMD's oral hormone therapy for menopause symptoms such as hot flashes, sleep disturbances and night sweats, the company said on Monday.

FDA approves TherapeuticsMD's menopause drug

Oct 29 The U.S. Food and Drug Administration approved TherapeuticsMD's oral hormone therapy for menopause symptoms such as hot flashes, sleep disturbances and night sweats, the company said on Monday.

Select another date: